Old Web
English
Sign In
Acemap
>
authorDetail
>
Celine J. van de Laar
Celine J. van de Laar
Rheumatoid arthritis
Medicine
Internal medicine
Biologic Disease-Modifying Antirheumatic Drug
treat to target
2
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
2020
ClinicoEconomics and Outcomes Research
Celine J. van de Laar
Martijn A.H. Oude Voshaar
Walid Fakhouri
Liliana Zaremba-Pechmann
Francesco De Leonardis
Inmaculada de la Torre
Mart A F J van de Laar
Show All
Source
Cite
Save
Citations (4)
OP0313 COST-EFFECTIVENESS OF A JAK1/JAK2-INHIBITOR VS. A BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUG IN A TREAT-TO-TARGET STRATEGY FOR RHEUMATOID ARTHRITIS
2019
Annals of the Rheumatic Diseases
Celine J. van de Laar
Martijn A.H. Oude Voshaar
Walid Fakhouri
Liliana Zaremba-Pechmann
Francesco De Leonardis
Inmaculada de la Torre
Mart A F J van de Laar
Show All
Source
Cite
Save
Citations (1)
1